The pandemic coronavirus disease 2019 (COVID-19) is an infectious disease caused by a newly discovered coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 attaches to the host cell surface and enters cells by Spike recognizing Angiotensin-Converting Enzyme 2 (ACE2) receptor which is found on many cell types. Drugs targeting the interaction between the Spike protein and ACE2 can inhibit the virus infection.

RGBiotech offers COVID-19 coronavirus research tools to accelerate the progress of your antiviral drug development.

1. Plasmids for producing SARS-CoV-2 S pseudotyped reporter lentivirus

2. Plasmids for generating SARS-CoV-2 related stable cell lines

3. SARS-CoV-2 ORF plasmids

Contact Us